NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Forecast

$0.255
+0 (+0%)
At Close: May 27, 2022
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Conatus Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Conatus Pharmaceuticals Inc. is CNAT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Conatus Pharmaceuticals Inc. Stock?
Conatus Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Conatus Pharmaceuticals Inc. Stock?
Conatus Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Conatus Pharmaceuticals Inc. Stock.

What's the current price of Conatus Pharmaceuticals Inc. Stock?
As of the end of day on the 2022-05-27, the price of an Conatus Pharmaceuticals Inc. (CNAT) share was $0.255.

What is the 52-week high and low for Conatus Pharmaceuticals Inc. Stock?
The 52-week high for Conatus Pharmaceuticals Inc. Stock is $1.23 and the 52-week low is $0.203.
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT